Understanding cognitive decline in older adults with psychotic disorders over 35 years

Trajectories and Determinants of Cognitive Decline in Psychotic Disorders Over 35 Years

NIH-funded research State University New York Stony Brook · NIH-11009583

This study is looking at how thinking and memory skills change as older adults with psychotic disorders age, to better understand when these changes start and how they affect daily life, and it’s for people aged 65 and up who have experienced psychosis.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionState University New York Stony Brook NIH-funded
Lab location1 site (Stony Brook, United States)
Project IDNIH-11009583 on NIH RePORTER

What this research studies

This research investigates how cognitive decline progresses in individuals with psychotic disorders as they age, particularly focusing on those who are 65 years and older. By analyzing data from a long-term study that has followed participants since their first episode of psychosis, the research aims to identify when cognitive decline begins, its causes, and its effects on daily functioning. Participants will undergo comprehensive evaluations, including cognitive tests and medical assessments, to gather insights into their mental health trajectory. The study seeks to compare the cognitive decline of those with psychotic disorders to that of matched individuals without such disorders.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals aged 65 and older who have a history of psychotic disorders.

Not a fit: Patients who are younger than 65 or do not have a diagnosis of a psychotic disorder may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and management of cognitive decline in older adults with psychotic disorders, potentially enhancing their quality of life.

How similar studies have performed: Previous research has shown promising results in understanding cognitive decline in psychotic disorders, but this specific long-term approach is relatively novel.

Where this research is happening

Stony Brook, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.